McKesson: Number of Employees 2010-2024 | MCK

Interactive chart of McKesson (MCK) annual worldwide employee count from 2010 to 2024.
  • McKesson total number of employees in 2024 was 51,000, a 0% decline from 2023.
  • McKesson total number of employees in 2023 was 51,000, a 32% decline from 2022.
  • McKesson total number of employees in 2022 was 75,000, a 1.32% decline from 2021.
  • McKesson total number of employees in 2021 was 76,000, a 5% decline from 2020.
McKesson Annual Employee Count
2024 51,000
2023 51,000
2022 75,000
2021 76,000
2020 80,000
2019 80,000
2018 78,000
2017 78,000
2016 68,000
2015 70,400
2014 42,800
2013 43,500
2012 37,700
2011 36,400
2010 32,500
2009 32,500
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $78.372B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.726B 25.90
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00